Canine Infectious Tracheobronchitis: Effects of an Intranasal Live Canine Parainfluenza-Bordetella bronchiseptica Vaccine on Viral Shedding and Clinical Tracheobronchitis (Kennel Cough)

Abstract

SUMMARY A modified-live intranasal (in) canine parainfluenza (cpi)-virus Bordetella bronchiseptica vaccine was evaluated in dogs for efficacy against laboratory-induced canine infectious tracheobronchitis. The comparative efficacies of in and parenteral administrations of the cpi virus fraction were also evaluated. The frequency and duration of clinical tracheobronchitis, blood serum agglutination titer, humoral antibody response, and duration of cpi virus and B bronchiseptica shedding were measured. Group A dogs were vaccinated subcutaneously or im with an experimental cpi vaccine and challenge exposed with cpi virus. Group B dogs were vaccinated in with avirulent cpi virus-B bronchiseptica live antigens and challenge exposed with virulent cpi virus and virulent B bronchiseptica. The in vaccination (group B) significantly reduced (P ≤ 0.001) the occurrence of clinical tracheobronchitis by 96%. The combined challenge exposure of virulent cpi and virulent B bronchiseptica produced a synergistic enhancement of the clinical signs of kennel cough. The percentage of days after challenge exposure that virus shedding was detected for controls equaled 70% as compared with 50% and only 1% for parenterally and in vaccinated dogs, respectively. Isolation of virulent B bronchiseptica microorganisms was reduced 89% in dogs vaccinated in compared with controls. The geometric mean humoral antibody titers to cpi virus after 2 parenteral vaccinations and 1 in vaccination were 1:43 and 1:34, respectively.